Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Trauma Injury
Interventions: Immunofluorescence Imaging; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Cataract Senile
Interventions: Cataract Surgery; Device
Lead sponsor: Carl Zeiss Meditec, Inc.; Industry
Eligibility: 22 Years to 100 Years
Enrollment: 284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 14
States / cities: Beverly Hills, California • Northridge, California • Orange, California + 11 more

Conditions: Infertility, Recurrent Miscarriage
Interventions: Influenza Vaccine, Sterile Saline; Biological · Other
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: Aerobic Exercise and Relaxation, Aerobic Exercise Only, Relaxation Only; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Human Papillomavirus Vaccination
Interventions: Counseling; Behavioral
Lead sponsor: Plan A Health, Inc; Other
Eligibility: 18 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Louise, Mississippi

Conditions: Cystic Fibrosis
Interventions: Lung T1 MRI; Diagnostic Test
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 5 Years to 11 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Indianapolis, Indiana • Ann Arbor, Michigan • Cleveland, Ohio

Conditions: Lennox Gastaut Syndrome
Interventions: Carisbamate; Drug
Lead sponsor: SK Life Science, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 5
States / cities: Baltimore, Maryland • Lebanon, New Hampshire • Portland, Oregon + 2 more

Conditions: Sleep Apnea Syndromes
Interventions: CPAP; Device
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Lisdexamfetamine; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 12 Years to 30 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Retinal Disease, Macular Degeneration, Hereditary Retinal Dystrophy, Optic Nerve Disease, Glaucoma
Interventions: RB (Retrobulbar), ST (Subtenon), IV (Intravenous), IVIT (Intravitreal), IO (Intraocular); Procedure
Lead sponsor: MD Stem Cells; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Westport, Connecticut

Conditions: Myeloma
Interventions: Pomalidomide, Dexamethasone, Cyclophosphamide; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 3
States / cities: San Francisco, California • Tampa, Florida • New York, New York

Conditions: Infant, Premature, Diseases, Infant, Small for Gestational Age
Interventions: Individualized Nutrition, Optimized nutrition; Dietary Supplement
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Up to 7 Days
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: Investigational inhaled insulin (Technosphere), Artificial Pancreas (AP) device (APS©); Drug · Device
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 21 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Wet Age Related Macular Degeneration, wAMD
Interventions: EYP-1901, Aflibercept (2.0 mg); Drug
Lead sponsor: EyePoint Pharmaceuticals, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 76
States / cities: Phoenix, Arizona • Springdale, Arkansas • Bakersfield, California + 70 more

Conditions: Aging
Interventions: Cafe Move; Behavioral
Lead sponsor: University of Montana; Other
Eligibility: 50 Years to 85 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Missoula, Montana

Conditions: Lung Diseases, Interstitial
Interventions: Not listed
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 114,921 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Ridgefield, Connecticut

Conditions: Sturge-Weber Syndrome
Interventions: Brain magnetic resonance imaging, Neuro-psychology testing; Diagnostic Test · Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 3 Months to 30 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 40 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Cystic Fibrosis
Interventions: Not listed
Lead sponsor: National Jewish Health; Other
Eligibility: 6 Years to 99 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 19
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 15 more

Conditions: Type 1 Diabetes
Interventions: Enlite 3 Sensor; Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 14 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 2
States / cities: Walnut Creek, California • Renton, Washington

Conditions: High Intensity Interval Training, Overweight and Obesity, Metabolic Disease, Cognition
Interventions: HIIT Exercise Intervention, Stretching Intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 12 Years to 16 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Preterm Birth
Interventions: Unconditional Cash Transfer (High-Value), Unconditional Cash Transfer (Low-Value); Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Heart Failure
Interventions: Serelaxin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: Up to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Denver, Colorado • St Louis, Missouri • The Bronx, New York + 2 more

Conditions: COVID-19, COVID-19 Vaccines, Immunogenicity, Vaccine
Interventions: Observational; Other
Lead sponsor: Epividian; Industry
Eligibility: 18 Years and older
Enrollment: 825 participants
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

ICG Fluorescence Imaging in Trauma Patients

AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal

Effect of Influenza Vaccination on Donor Egg Recipient Outcomes

Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial

Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi

Evaluation of Lung T1-MRI in Pediatric Cystic Fibrosis Patients

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)

Lisdexamfetamine's Effect In ADHD in the Brain and Cognition

Stem Cell Ophthalmology Treatment Study

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants

Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Longitudinal Neuroimaging in Sturge-Weber Syndrome

Functional Social Support in COPD Self-Management

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

A Performance Evaluation of the Enlite 3 Sensor

The HIIT Cognition Study

COIN: A Pilot Study of Cash Transfers to Improve Outcomes in Low-Income Preterm Neonates and Their Families

Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure

COVID-19 Quantitative Antibody Titers & Booster Vaccinations